Insider Trading June 18, 2026 06:31 PM

DENTSPLY SIRONA Director Jonathan Mazelsky Acquires $101,400 in Shares Amid Strategic Expansion

Insider purchase aligns with recent revenue beat and new distribution partnership, though valuation metrics suggest underlying challenges.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
XRAY

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) director Jonathan Jay Mazelsky recently executed an open market purchase of 10,000 shares on June 12, 2026, totaling $101,400 at $10.14 per share. This acquisition, clarified in a recent SEC filing amendment, brings his direct holdings to 61,668.534 shares. The transaction occurs as the dental equipment manufacturer navigates a mixed first-quarter 2026 financial report, where revenue exceeded forecasts but earnings per share fell short. Concurrently, the company has announced an expanded distribution agreement with Nashville Dental, signaling ongoing strategic growth initiatives despite broader market headwinds.

DENTSPLY SIRONA Director Jonathan Mazelsky Acquires $101,400 in Shares Amid Strategic Expansion
XRAY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director Jonathan Mazelsky purchased 10,000 shares for $101,400 on June 12, 2026, bringing his total direct holdings to 61,668.534 shares.
  • DENTSPLY SIRONA reported Q1 2026 revenue of $880 million, beating the $842.58 million forecast, driven by favorable currency conditions.
  • The company announced an expanded distribution agreement with Nashville Dental for August 1, 2026, covering connected technology solutions across nine states.

Jonathan Jay Mazelsky, a director at DENTSPLY SIRONA Inc. (NASDAQ:XRAY), has executed a significant open market purchase of the company's equity, according to a recent filing with the Securities and Exchange Commission. On June 12, 2026, Mazelsky acquired 10,000 shares of common stock at a price of $10.14 per share, bringing the total transaction value to $101,400. This transaction was clarified in an amended filing, confirming it as a direct open market acquisition. Following this acquisition, Mazelsky's direct holdings in DENTSPLY SIRONA common stock stand at 61,668.534 shares.


The timing of this insider purchase is notable given the company's recent market performance. DENTSPLY SIRONA's stock has experienced significant downward pressure, trading near its 52-week low of $9.40 and reflecting a 30% decline over the past year. Despite these headwinds, the company continues to offer a 6.2% dividend yield, having maintained consistent dividend payments for 32 consecutive years. According to InvestingPro analysis, the current valuation places DENTSPLY SIRONA among stocks considered undervalued at present levels.


In other recent developments, DENTSPLY SIRONA reported its first-quarter 2026 financial results, presenting a mixed performance profile. The company's revenue surpassed market expectations, reaching $880 million compared to the forecasted $842.58 million. This revenue beat was primarily driven by favorable currency conditions. However, the company's earnings per share fell short of predictions, coming in at $0.27 against an anticipated $0.28.


Strategically, DENTSPLY SIRONA has announced an expanded distribution agreement with Nashville Dental, effective August 1, 2026. This partnership will encompass the company's connected technology solutions, including the CEREC system and Primescan intraoral scanners, across a nine-state territory. Despite these strategic initiatives, analyst sentiment remains cautious. Needham has maintained a Hold rating on the company's stock, citing execution risks associated with the ongoing business environment.

Risks

  • Earnings per share fell short of expectations at $0.27 versus the anticipated $0.28, indicating potential margin or cost pressures.
  • Analyst Needham maintains a Hold rating, citing execution risks that could impact the company's strategic initiatives and market performance.
  • The stock has declined 30% over the past year and is trading near its 52-week low of $9.40, reflecting broader market skepticism.

More from Insider Trading

WEX Inc. COO Robert Deshaies Disposes of $184,950 in Shares Amid Strong Q2 Performance Jul 31, 2026 NPEH, LLC Divests 255,858 NET Power Shares Amid Earnings Miss and Near 52-Week Low Jul 30, 2026 Block Director Executes Pre-Arranged Sale as Analysts Adjust Pricing Models Ahead of Q2 Earnings Jul 30, 2026 Viking Therapeutics Executive Liquidates Shares to Cover Vesting Tax Obligations Jul 29, 2026 TransUnion Executive Sells Equity as Q2 Earnings Beat Consensus Estimates Jul 29, 2026